Carolyn B. Hendricks

3.1k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Carolyn B. Hendricks is a scholar working on Oncology, Cancer Research and Economics and Econometrics. According to data from OpenAlex, Carolyn B. Hendricks has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Cancer Research and 6 papers in Economics and Econometrics. Recurrent topics in Carolyn B. Hendricks's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Carolyn B. Hendricks is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Carolyn B. Hendricks collaborates with scholars based in United States, Mexico and South Africa. Carolyn B. Hendricks's co-authors include Eric K. Rowinsky, Scott H. Kaufmann, Patricia J. Eifel, W.J. Curran, Janitha Costa, Sarah Fulton, Robert J. Mayer, Jan Axelson, Debra Roter and Maurie Markman and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Carolyn B. Hendricks

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

2001 712 citations Patricia J. Eifel, Jan Axelson et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carolyn B. Hendricks United States	11	920	637	618	199	194	31	1.6k
Carole Tarpin France	17	1.1k 1.2×	857 1.3×	723 1.2×	166 0.8×	156 0.8×	51	2.0k
Irma Fredriksson Sweden	22	946 1.0×	281 0.4×	805 1.3×	231 1.2×	263 1.4×	64	1.5k
Erin Hofstatter United States	21	812 0.9×	500 0.8×	612 1.0×	463 2.3×	203 1.0×	60	1.9k
Christine Brezden‐Masley Canada	24	1.1k 1.2×	311 0.5×	440 0.7×	140 0.7×	191 1.0×	106	2.1k
N Stuart United Kingdom	18	744 0.8×	781 1.2×	503 0.8×	116 0.6×	141 0.7×	36	1.9k
Nils‐Olof Bengtsson Sweden	19	1.1k 1.2×	436 0.7×	763 1.2×	230 1.2×	156 0.8×	35	2.0k
Cynthia Osborne United States	9	1.0k 1.1×	441 0.7×	432 0.7×	233 1.2×	92 0.5×	12	1.5k
Ellen Schlichting Norway	21	834 0.9×	420 0.7×	676 1.1×	457 2.3×	224 1.2×	44	1.6k
John F. Sandbach United States	15	1.5k 1.6×	661 1.0×	864 1.4×	413 2.1×	214 1.1×	32	2.4k
Ted Vandenberg Canada	19	1.4k 1.5×	381 0.6×	761 1.2×	279 1.4×	160 0.8×	39	2.0k

Countries citing papers authored by Carolyn B. Hendricks

Since Specialization

Citations

This map shows the geographic impact of Carolyn B. Hendricks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn B. Hendricks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn B. Hendricks more than expected).

Fields of papers citing papers by Carolyn B. Hendricks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn B. Hendricks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn B. Hendricks. The network helps show where Carolyn B. Hendricks may publish in the future.

Co-authorship network of co-authors of Carolyn B. Hendricks

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn B. Hendricks. A scholar is included among the top collaborators of Carolyn B. Hendricks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn B. Hendricks. Carolyn B. Hendricks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hendricks, Carolyn B., Ignatius M. Viljoen, Estelle Verburgh, et al.. (2025). Progress in advanced cellular and gene therapies in South Africa and barriers to patient access: A National Consortium paper on behalf of the BloodSA Cell and Gene Therapy working party. South African Medical Journal. 115(5). e3070–e3070.

Hendricks, Carolyn B., et al.. (2023). Prevalence of malnutrition and its impact on outcomes in children with cancer in a South African setting. South African Journal of Child Health. 181–185. 2 indexed citations

Bernicker, Eric, Stephen B. Edge, Fadlo R. Khuri, et al.. (2023). Climate Change and Cancer Care: A Policy Statement From ASCO. JCO Oncology Practice. 20(2). 178–186. 11 indexed citations

Chávarri-Guerra, Yanin, Carolyn B. Hendricks, Terrence P. Cescon, et al.. (2020). Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer. Journal of Geriatric Oncology. 12(5). 749–751. 8 indexed citations

Chávarri-Guerra, Yanin, Carolyn B. Hendricks, Sandra M. Brown, et al.. (2019). The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients. Journal of the American Geriatrics Society. 67(5). 884–888. 10 indexed citations

Slavin, Thomas P., Jeff Longmate, Danielle Castillo, et al.. (2019). Effect of germline ATM mutations on clonal hematopoiesis.. Journal of Clinical Oncology. 37(15_suppl). 1509–1509. 2 indexed citations

Jahanzeb, Mohammad, Terry Gilmore, Stephen S. Grubbs, et al.. (2018). Can measuring quality lead to improvement? Evidence from international participants of ASCO’s quality oncology practice initiative (QOPI®) during 2015-2017. Annals of Oncology. 29. viii571–viii571. 1 indexed citations

Miller, Kathy D., Anne O’Neill, William J. Gradishar, et al.. (2018). Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103). Journal of Clinical Oncology. 36(25). 2621–2629. 47 indexed citations

Neuss, Michael N., Terry Gilmore, Amy L. Billett, et al.. (2017). 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Oncology nursing forum. 44(1). 31–43. 62 indexed citations

10.

Neuss, Michael N., Terry Gilmore, Amy L. Billett, et al.. (2016). 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Journal of Oncology Practice. 12(12). 1262–1271. 75 indexed citations

11.

Yardley, Denise A., N. W. Peacock, Mythili Shastry, et al.. (2015). A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score. Breast Cancer Research and Treatment. 154(2). 299–308. 45 indexed citations

12.

Hendricks, Carolyn B.. (2013). Re-Engineering a Small Oncology Practice for Quality Using the ASCO Quality Oncology Practice Initiative. Journal of Oncology Practice. 9(3). 169–170. 2 indexed citations

13.

Yardley, DA, Carolyn B. Hendricks, Charles Webb, et al.. (2012). Abstract P1-14-14: Neoadjuvant Sunitinib (S) Administered with Weekly Paclitaxel (P)/Carboplatin(C) in Patients (Pts) with Locally Advanced Triple-Negative Breast Cancer (TNBC): Preliminary Results from a Phase I/II Trial of the Sarah Cannon Research Institute.. Cancer Research. 72(24_Supplement). P1–14. 1 indexed citations

14.

Peacock, N. W., DA Yardley, Carolyn B. Hendricks, et al.. (2011). Ixabepilone and cyclophosphamide as neoadjuvant therapy in HER2-negative breast cancer with exploratory Oncotype DX assessments: A Sarah Cannon Research Institute phase II trial.. Journal of Clinical Oncology. 29(15_suppl). 1066–1066. 2 indexed citations

15.

Hendricks, Carolyn B., et al.. (2011). P5-13-09: Correlation of Oncotype DX Recurrence Scores with Pathologic Response Following Neoadjuvant Ixabepilone and Cyclophosphamide in Patients with HER2−Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.. Cancer Research. 71(24_Supplement). P5–13. 5 indexed citations

16.

Hendricks, Carolyn B., et al.. (2006). Internet based double-blind cross-over clinical trial to test efficacy of high dose isoflavone soy in controlling breast cancer survivor hot flashes. Journal of Clinical Oncology. 24(18_suppl). 636–636. 1 indexed citations

17.

Eifel, Patricia J., Jan Axelson, Janitha Costa, et al.. (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. JNCI Journal of the National Cancer Institute. 93(13). 979–989. 712 indexed citations breakdown →

18.

Rowinsky, Eric K., L B Grochow, Carolyn B. Hendricks, et al.. (1992). Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.. Journal of Clinical Oncology. 10(4). 647–656. 302 indexed citations

19.

Hendricks, Carolyn B., Eric K. Rowinsky, Louise B. Grochow, Ross C. Donehower, & Scott H. Kaufmann. (1992). Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.. PubMed. 52(8). 2268–78. 185 indexed citations

20.

Schuchter, Lynn M., Carolyn B. Hendricks, Kent Holland, et al.. (1990). Eosinophilic myocarditis associated with high-dose interleukin-2 therapy. The American Journal of Medicine. 88(4). 439–440. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact